Connor, Clark & Lunn Investment Management (CC&L)’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,319
Closed -$528K 1581
2024
Q3
$528K Sell
7,319
-4,211
-37% -$298K ﹤0.01% 1085
2024
Q2
$794K Buy
+11,530
New +$781K ﹤0.01% 913
2023
Q4
Sell
-27,009
Closed -$1.54M 1514
2023
Q3
$1.54M Sell
27,009
-3,637
-12% -$220K 0.01% 690
2023
Q2
$1.82M Buy
30,646
+27,448
+858% +$1.64M 0.01% 627
2023
Q1
$200K Sell
3,198
-8,975
-74% -$560K ﹤0.01% 1099
2022
Q4
$762K Sell
12,173
-23,362
-66% -$1.34M ﹤0.01% 773
2022
Q3
$1.77M Sell
35,535
-2,871
-7% -$159K 0.01% 517
2022
Q2
$2.26M Buy
38,406
+22,703
+145% +$1.25M 0.01% 449
2022
Q1
$831K Buy
15,703
+8,890
+130% +$513K ﹤0.01% 696
2021
Q4
$413K Buy
+6,813
New +$404K ﹤0.01% 833
2020
Q3
Sell
-28,173
Closed -$1.06M 1072
2020
Q2
$1.06M Buy
+28,173
New +$1.13M 0.01% 598
2014
Q4
Sell
-13,300
Closed -$431K 627
2014
Q3
$431K Buy
13,300
+3,200
+32% +$107K ﹤0.01% 412
2014
Q2
$365K Sell
10,100
-24,500
-71% -$785K ﹤0.01% 429
2014
Q1
$1.04M Buy
+34,600
New +$1.03M 0.01% 377

Other funds holding PBH

Connor, Clark & Lunn Investment Management (CC&L)'s PBH Position: Q4 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Prestige Consumer Healthcare (PBH) in Q4 2024, closing a stake of 7,319 shares — an estimated $528K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in PBH in Q1 2014 and held it in 14 quarters. The position peaked at $2.26M in Q2 2022. 336 funds tracked by Wall St. Rank hold PBH as of Q4 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Prestige Consumer Healthcare position as of Q4 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 7,319 Prestige Consumer Healthcare shares in Q4 2024, an estimated $528K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Prestige Consumer Healthcare in Q1 2014 and held it in 14 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Prestige Consumer Healthcare position peaked at $2.26M in Q2 2022.
  • 336 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q4 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q4 2024, filed 10 Feb 2025.